Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Fan Yang(Jinan University), Li Yang(Guangxi Medical University), Panlong Li(Sun Yat-sen University), Cong Du(Third Affiliated Hospital of Sun Yat-sen University), Regina Wanju Wong, Jintao Cheng(Sun Yat-sen University), Wenjie Chen(Sun Yat-sen University), Jianxi Lu(Sun Yat-sen University), Tingting Wang(Nationwide Children's Hospital), Yunhao Chen(Shanxi Agricultural University), Wanxin Chen(Energy Storage Systems (United States)), Sarene Koh(Singapore Immunology Network), Lu‐En Wai(Duke-NUS Medical School), Xiaoyan Chen(Sun Yat-sen University), Xiaofang Zheng(Hunan University), Qi Zhang(Sun Yat-sen University)
Hepatology International
April 17, 2023
Cited by 31


Related Papers